Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the kirki domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/dazzling-chebyshev.103-73-189-254.plesk.page/httpdocs/wp-includes/functions.php on line 6170

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the newspapers domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/dazzling-chebyshev.103-73-189-254.plesk.page/httpdocs/wp-includes/functions.php on line 6170
{"id":3923,"date":"2021-03-22T13:57:42","date_gmt":"2021-03-22T08:27:42","guid":{"rendered":"https:\/\/dazzling-chebyshev.103-73-189-254.plesk.page\/?p=3923"},"modified":"2021-03-22T13:57:42","modified_gmt":"2021-03-22T08:27:42","slug":"oral-covid-19-vaccine-on-the-way","status":"publish","type":"post","link":"https:\/\/dazzling-chebyshev.103-73-189-254.plesk.page\/?p=3923","title":{"rendered":"Oral Covid-19 vaccine on the way"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

<\/p>\n

\n

Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, with Oramed Pharmaceuticals, announced the development of an oral Covid-19 vaccine that has shown efficacy after a single dose.<\/strong><\/p>\n<\/blockquote>\n

<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Premas, Oramed and other shareholders, have formed Oravax Medical, which has received exclusive licenses from Oramed and Premas to develop oral COVID-19 vaccines.<\/p>\n

After a single dose of the Oravax COVID-19 capsule, efficacy was evident through antibody production in a pilot animal study. Oravax\u2019s vaccine promoted both systemic immunity through Immunoglobulin G (IgG), the most common antibody in blood and bodily fluids that protects against viral infections and Immunoglobulin A (IgA) which protects the respiratory and gastrointestinal tracts against infection.<\/p>\n

Premas\u2019 protein-based VLP (virus-like particle) vaccine candidate creates triple protection against the SARS CoV-2 virus spike, membrane, and envelope targets. The vaccine candidate is also safe, efficacious and well-tolerated at normal to high doses, and generated high titres of neutralizing antibodies. The VLP is manufactured using Premas\u2019 proprietary D-Crypt platform, which is highly scalable and can be manufactured on large scales.<\/p>\n

\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u00a0An oral Covid-19 vaccine that harnesses and combines the true potential of Premas\u2019 D-Crypt technology platform with Oramed\u2019s world-leading oral protein delivery platform, POD is an excellent example of collaboration and can rapidly advance into late-stage clinical trials, says Dr Prabuddha Kundu, Premas Biotech Co-Founder and Managing Director. Oramed\u2019s experience and success in conducting Phase 2 and 3 oral protein trials position its program favourably in the race to find an effective oral Covid-19 vaccine that can be administered by anyone anywhere. The company is expected to share clinical data soon.<\/p>\n

An oral COVID-19 vaccine would eliminate several barriers to rapid, wide-scale distribution, enabling people to take the vaccine themselves at home, says Nadav Kidron, CEO of Oramed.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t
Nadav Kidron - CEO of Oramed<\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Premas, Oramed and other shareholders, have formed Oravax Medical, which has received exclusive licenses from Oramed and Premas to develop oral COVID-19 vaccines.<\/p>\n","protected":false},"author":4,"featured_media":3925,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[31,45],"tags":[108],"class_list":["post-3923","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-care","category-new-launch","tag-covid-19"],"_links":{"self":[{"href":"https:\/\/dazzling-chebyshev.103-73-189-254.plesk.page\/index.php?rest_route=\/wp\/v2\/posts\/3923","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dazzling-chebyshev.103-73-189-254.plesk.page\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dazzling-chebyshev.103-73-189-254.plesk.page\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dazzling-chebyshev.103-73-189-254.plesk.page\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/dazzling-chebyshev.103-73-189-254.plesk.page\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3923"}],"version-history":[{"count":0,"href":"https:\/\/dazzling-chebyshev.103-73-189-254.plesk.page\/index.php?rest_route=\/wp\/v2\/posts\/3923\/revisions"}],"wp:attachment":[{"href":"https:\/\/dazzling-chebyshev.103-73-189-254.plesk.page\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3923"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dazzling-chebyshev.103-73-189-254.plesk.page\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3923"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dazzling-chebyshev.103-73-189-254.plesk.page\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}